I’d like a phonecard, please traiter viagra Quest Diagnostics Inc. (DGX)–encouraged by a Supreme Court ruling this summer that invalidated patent rights for human DNA–has begun selling a genetic screening test used to predict the risk of breast and ovarian cancer.
Cleveland
